Skip to main content
logo
Influx Healthtech Limited (NSE:INFLUX)
India flag India · Delayed Price · Currency is INR
296.45
+11.15 (3.91%)
At close: Jul 31, 2026

Influx Healthtech Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
1,4681,4681,049999.65760.57592.02
Revenue Growth
40.04%40.04%4.89%31.44%28.47%-
Gross Profit
601.43601.43409.05343.65231.94135.64
Operating Income
274.15274.15178.46151.2897.8660.48
Net Income
205.39205.39133.66111.2871.9644.37
Earnings Per Share
9.359.357.366.133.962.44
EPS Growth
27.04%27.04%20.06%54.80%62.00%-

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
274.65274.6519.1136.0635.4714.65
Total Debt
--2.193.257.996.1
Net Cash (Debt)
274.65274.6516.9132.8127.498.55
Net Cash Growth
1523.82%1523.82%-48.45%19.36%221.40%3766.52%
Net Cash Per Share
12.5012.500.931.811.510.47

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
38.8738.8770.5689.4368.2229.12
Capital Expenditures
-245.62-245.62-82.11-83.6-48.8-28.63
Free Cash Flow
-206.75-206.75-11.555.8319.430.49
Free Cash Flow Growth
----70.00%3856.82%-

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
40.96%40.96%39.01%34.38%30.50%22.91%
Operating Margin
18.67%18.67%17.02%15.13%12.87%10.22%
Pretax Margin
18.55%18.55%17.05%14.94%12.80%10.14%
Profit Margin
13.99%13.99%12.75%11.13%9.46%7.49%
FCF Margin
-14.08%-14.08%-1.10%0.58%2.55%0.08%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
31.7122.77----
PS Ratio
4.673.19----